Cancer Letters
Volume 275, Issue 1 , Pages 86-92 , 8 March 2009

Suppression of androgen receptor signaling and prostate specific antigen expression by (−)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells

Received 15 August 2008 ,Revised 1 October 2008 ,Accepted 2 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(08)00811-2

doi: 10.1016/j.canlet.2008.10.001

Cancer Letters
Volume 275, Issue 1 , Pages 86-92 , 8 March 2009